Zobrazeno 1 - 1
of 1
pro vyhledávání: '"You‐Kuang Kang"'
Autor:
You‐Kuang Kang, Fan‐Chun Meng
Publikováno v:
Thoracic Cancer, Vol 13, Iss 7, Pp 1091-1094 (2022)
Abstract Osimertinib is the most efficient first‐line drug, with least adverse effects, for metastatic non‐small‐cell lung carcinoma (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations with exon 19 deletion or exon 21 L858R muta
Externí odkaz:
https://doaj.org/article/3bbc8cfcba894a0c873131659b37ed4f
